175 related articles for article (PubMed ID: 30930189)
1. Acoustic levitation as a screening method for excipient selection in the development of dry powder vaccines.
Morgan BA; Xing Z; Cranston ED; Thompson MR
Int J Pharm; 2019 May; 563():71-78. PubMed ID: 30930189
[TBL] [Abstract][Full Text] [Related]
2. Validation of a diffusion-based single droplet drying model for encapsulation of a viral-vectored vaccine using an acoustic levitator.
Morgan BA; Niinivaara E; Xing Z; Thompson MR; Cranston ED
Int J Pharm; 2021 Aug; 605():120806. PubMed ID: 34144140
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of excipients for enhanced thermal stabilization of a human type 5 adenoviral vector through spray drying.
LeClair DA; Cranston ED; Xing Z; Thompson MR
Int J Pharm; 2016 Jun; 506(1-2):289-301. PubMed ID: 27130366
[TBL] [Abstract][Full Text] [Related]
4. Excipient selection for thermally stable enveloped and non-enveloped viral vaccine platforms in dry powders.
Toniolo SP; Afkhami S; Mahmood A; Fradin C; Lichty BD; Miller MS; Xing Z; Cranston ED; Thompson MR
Int J Pharm; 2019 Apr; 561():66-73. PubMed ID: 30825554
[TBL] [Abstract][Full Text] [Related]
5. Optimization of Spray Drying Conditions for Yield, Particle Size and Biological Activity of Thermally Stable Viral Vectors.
LeClair DA; Cranston ED; Xing Z; Thompson MR
Pharm Res; 2016 Nov; 33(11):2763-76. PubMed ID: 27450412
[TBL] [Abstract][Full Text] [Related]
6. Internal microstructure of spray dried particles affects viral vector activity in dry vaccines.
Singh V; Morgan BA; Schertel A; Dolovich M; Xing Z; Thompson MR; Cranston ED
Int J Pharm; 2023 Jun; 640():122988. PubMed ID: 37121491
[TBL] [Abstract][Full Text] [Related]
7. The effect of formulation on spray dried Sabin inactivated polio vaccine.
Kanojia G; Ten Have R; Brugmans D; Soema PC; Frijlink HW; Amorij JP; Kersten G
Eur J Pharm Biopharm; 2018 Aug; 129():21-29. PubMed ID: 29787800
[TBL] [Abstract][Full Text] [Related]
8. Designing CAF-adjuvanted dry powder vaccines: spray drying preserves the adjuvant activity of CAF01.
Ingvarsson PT; Schmidt ST; Christensen D; Larsen NB; Hinrichs WL; Andersen P; Rantanen J; Nielsen HM; Yang M; Foged C
J Control Release; 2013 May; 167(3):256-64. PubMed ID: 23415813
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of spray drying bacteriophages into respirable powders to combat pulmonary bacterial infections.
Vandenheuvel D; Singh A; Vandersteegen K; Klumpp J; Lavigne R; Van den Mooter G
Eur J Pharm Biopharm; 2013 Aug; 84(3):578-82. PubMed ID: 23353012
[TBL] [Abstract][Full Text] [Related]
10. Drying of a single droplet of dextrin: Drying kinetics modeling and particle formation.
Al Zaitone B; Al-Zahrani A; Al-Shahrani S; Lamprecht A
Int J Pharm; 2020 Jan; 574():118888. PubMed ID: 31786353
[TBL] [Abstract][Full Text] [Related]
11. Developments in the formulation and delivery of spray dried vaccines.
Kanojia G; Have RT; Soema PC; Frijlink H; Amorij JP; Kersten G
Hum Vaccin Immunother; 2017 Oct; 13(10):2364-2378. PubMed ID: 28925794
[TBL] [Abstract][Full Text] [Related]
12. Effect of thermal and shear stresses in the spray drying process on the stability of siRNA dry powders.
Wu J; Wu L; Wan F; Rantanen J; Cun D; Yang M
Int J Pharm; 2019 Jul; 566():32-39. PubMed ID: 31077763
[TBL] [Abstract][Full Text] [Related]
13. Bacteriophage Encapsulation Using Spray Drying for Phage Therapy.
Malik DJ
Curr Issues Mol Biol; 2021; 40():303-316. PubMed ID: 32678066
[TBL] [Abstract][Full Text] [Related]
14. Design and Optimization of a Temperature-Stable Dry Powder BCG Vaccine.
Price DN; Kunda NK; Ellis R; Muttil P
Pharm Res; 2019 Dec; 37(1):11. PubMed ID: 31873825
[TBL] [Abstract][Full Text] [Related]
15. Cryoprotective agents influence viral dosage and thermal stability of inhalable dry powder vaccines.
Manser M; Feng X; Xing Z; Cranston ED; Thompson MR
Int J Pharm; 2022 Apr; 617():121602. PubMed ID: 35189314
[TBL] [Abstract][Full Text] [Related]
16. Dextran Mass Ratio Controls Particle Drying Dynamics in a Thermally Stable Dry Powder Vaccine for Pulmonary Delivery.
Manser M; Morgan BA; Feng X; Rhem RG; Dolovich MB; Xing Z; Cranston ED; Thompson MR
Pharm Res; 2022 Sep; 39(9):2315-2328. PubMed ID: 35854077
[TBL] [Abstract][Full Text] [Related]
17. Effect of Shear Stresses on Adenovirus Activity and Aggregation during Atomization To Produce Thermally Stable Vaccines by Spray Drying.
Morgan BA; Manser M; Jeyanathan M; Xing Z; Cranston ED; Thompson MR
ACS Biomater Sci Eng; 2020 Jul; 6(7):4304-4313. PubMed ID: 33463328
[TBL] [Abstract][Full Text] [Related]
18. L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders.
Li L; Sun S; Parumasivam T; Denman JA; Gengenbach T; Tang P; Mao S; Chan HK
Eur J Pharm Biopharm; 2016 May; 102():132-41. PubMed ID: 26970252
[TBL] [Abstract][Full Text] [Related]
19. Production of cocrystals in an excipient matrix by spray drying.
Walsh D; Serrano DR; Worku ZA; Norris BA; Healy AM
Int J Pharm; 2018 Jan; 536(1):467-477. PubMed ID: 29241701
[TBL] [Abstract][Full Text] [Related]
20. Stabilization of HSV-2 viral vaccine candidate by spray drying.
LeClair DA; Li L; Rahman N; Cranston ED; Xing Z; Thompson MR
Int J Pharm; 2019 Oct; 569():118615. PubMed ID: 31415872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
